UBS raised the firm’s price target on RealReal (REAL) to $14 from $10.50 and keeps a Neutral rating on the shares. The company is growing sales and profit better than anticipated as evidenced by RealReal’s Q3 report, the analyst tells investors in a research note. RealReal’s efforts to unlock supply and drive operational efficiency are working, and these initiatives should continue driving sales and EBITDA growth, though the stock is mostly pricing this in, UBS adds.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on REAL:
- Balanced Risk-Reward Scenario for RealReal Amid Strong Performance and Macroeconomic Concerns
- The RealReal Reports Record Growth in Q3 2025
- Closing Bell Movers: CoreWeave down over 5% on lower sales, higher capex view
- RealReal raises FY25 revenue view to $687M-$690M from $667M-$674M
- RealReal sees Q4 revenue $188M-$191M, consensus $179.55M
